Timing is Everything: Early Chemotherapy Boosts Colorectal Cancer Survival
Study finds starting chemotherapy within 6 weeks after colorectal cancer surgery improves survival rates.
Cusatuzumab plus azacitidine shows efficacy in treating newly diagnosed acute myeloid leukemia
Study compares 10-day decitabine to standard chemo for older AML patients eligible for transplant
Study compares fosfomycin to ciprofloxacin for preventing infections in leukemia and transplant patients
Study evaluates quizartinib plus chemotherapy for relapsed/refractory acute myeloid leukemia with FLT3 mutations